November/December 2024

Featured Article

Editor's Page

Closing Out 2024: Advancing Value-Based Oncology Through Innovation and Equity

12/02/2024

Editor-in-Chief Winston Wong, PharmD, provides insights on this issue’s content, including reducing artificial intelligence-driven bias, the impact of the 340B program in the commercial employer market, and the cost-effectiveness of...

Editor-in-Chief Winston Wong,...

12/02/2024

Journal of Clinical Pathways

Feature

Perspectives

Taking the Garbage Out: Addressing AI Bias in Quality Measurement

12/02/2024

Maggie Dietrick , MPH;

Palak Patel , MHA;

Tom Valuck , MD, JD;

This article explores the use of artificial intelligence (AI) in health care quality measurement and tactics to mitigate bias in AI-enhanced measurement.

This article explores the use of...

12/02/2024

Journal of Clinical Pathways

Case Study

Development and Analysis of a Treatment Timeliness Dashboard for Patients With Head and Neck Cancer at a Tertiary Academic Multidisciplinary Clinic

12/02/2024

Martha J. Ryan , MSN, FNP-C;

;

Karoline Fendley , BSN, RN;

Nicole C. Schmitt , MD;

Mark W. El-Deiry , MD;

In this case study, researchers describe a treatment timeline dashboard for treating patients with head and neck cancer using a primary nursing care coordination model.

In this case study, researchers...

12/02/2024

Journal of Clinical Pathways

From the Field

Cost and Clinical Implications of Utilizing Homologous Recombination Deficiency Status to Guide First-Line Maintenance Therapy Selection in Advanced Ovarian Cancer

12/02/2024

Daniel Simmons , PharmD, MS;

Rebecca Stone , MD;

James Ryan , MSc;

Jigna Bhalla , PharmD;

;

This study models the clinical outcomes and costs associated with utilizing an HRD biomarker-guided (BMG) approach to first-line AOC maintenance compared with a non-biomarker-guided (NBMG) approach.

This study models the clinical...

12/02/2024

Journal of Clinical Pathways

Column

Transformative Employer Trends

Unintended Public Law Intent Has Private Sector Employer Plan Impacts

12/02/2024

F. Randy Vogenberg , PhD, FASHP;

This column examines how the 340B program and other similar legislation has unintended impacts on private employer health care plans.

This column examines how the...

12/02/2024

Journal of Clinical Pathways

MAI Mindset

Oncology Pathways Research: Challenges, Adoption, and Future Trends

12/02/2024

Cindy Chen , MBA;

In an exclusive interview with the Journal of Clinical Pathways, Cindy Chen, Head of Research at HMP Market Access Insights, shares insights into the challenges, adoption, and future trends of oncology pathways research.

In an exclusive interview with...

12/02/2024

Journal of Clinical Pathways

Department

Conference Highlights

Evolving Oncology Pathways, CLL Treatment Advances, and the Role of Multidisciplinary Care Teams

12/02/2024

Shaffee Bacchus , PharmD;

In this exclusive interview, Dr Bacchus highlights the evolution of treatment for chronic lymphocytic leukemia (CLL) and provides context regarding the complex needs of patients with CLL.

In this exclusive interview, Dr...

12/02/2024

Journal of Clinical Pathways

Current Issue

December 2024

Volume 10

Issue 6

Current Issue

Issue Archive

Special Reports

Sponsored

JCP Special Report

2024 NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) Update: Impact on NSCLC Landscape

11/15/2024

The updated 2024 NCCN Guidelines® recommend broad genomic testing and the need for multidisciplinary care to accurately diagnose and treat non-small cell lung cancer. View this special report to learn more.

The updated 2024 NCCN...

11/15/2024

Journal of Clinical Pathways

Sponsored

JCP Special Report

The Value of Tissue-Based Genomic Profiling in Oncology

09/17/2024

Innovations in precision oncology have helped healthcare providers to create more personalized treatment plans and improve patient outcomes. View this special report to learn more.

Innovations in precision...

09/17/2024

Journal of Clinical Pathways

Sponsored

Special Report

Shedding Light on Non-Small Cell Lung Cancer & Its Impact on Patients

04/03/2023

This supplement aims to raise awareness about non-small cell lung cancer (NSCLC) and its impact on patients by providing comprehensive information to help improve early detection and appropriate care.

This supplement aims to raise...

04/03/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Brukinsa® (Zanubrutinib) for Chronic Lymphocytic Leukemia

03/31/2023

In this product monograph, read an interview with Jeff P. Sharman, MD, as he discusses important BRUKINSA® trial data including efficacy, safety, dosing, administration, and other relevant data. These key findings supported the Food and Drug...

In this product monograph, read...

03/31/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Tumor Lysis Syndrome: Early Diagnosis and Management

01/04/2023

This review summarizes the diagnosis, pathophysiology, and evidence-based guidelines for the prevention and management of tumor lysis syndrome, a common, acute, life-threatening disease primarily in patients with hematologic cancers and solid...

This review summarizes the...

01/04/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

A Tumor Lysis Syndrome Risk Assessment and Its Impact on Patients

08/09/2022

In an interview with Journal of Clinical Pathways, Nicholas Short, MD, shares objectives on the design and benefits of MD Anderson’s Tumor Lysis Syndrome clinical assessment for patient risk and impact on patient care.

In an interview with Journal of...

08/09/2022

Journal of Clinical Pathways

Updated NCCN Guidelines on B-Cell Lymphomas

Sponsored

JCP Special Report

Overview of the Updated NCCN Guidelines on B-Cell Lymphomas

06/15/2022

Robert Fee ;

Updated multiple times in 2022, the National Comprehensive Cancer Network (NCCN) Guidelines for B-Cell Lymphomas provide recommendations for the prevention, diagnosis, and management of malignancies.

Updated multiple times in 2022,...

06/15/2022

Journal of Clinical Pathways

Sponsored

Special Report

Expanded Indication for Zanubrutinib: Marginal Zone Lymphoma and Waldenström’s Macroglobulinemia

06/10/2022

In an interview with Journal of Clinical Pathways, Mitul Gandhi, MD, reviews the clinical impact and treatment approaches and challenges for patients with marginal zone lymphoma and Waldenström’s macroglobulinemia.

In an interview with Journal of...

06/10/2022

Journal of Clinical Pathways

JCP Special Report

Recommendations for Creating an Oncology Clinical Pathways Framework Tool Based on Payer, Provider, and Patient Priorities: Findings From the 2021 Care Pathways Working Group

05/20/2022

Robin T. Zon , MD, FACP, FASCO;

Gordon Kuntz ;

Winston Wong , PharmD;

The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...

The Journal of Clinical Pathways...

05/20/2022

Journal of Clinical Pathways

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

Sponsored

Special Report

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

12/15/2021

Deborah Abrams Kaplan ;

NCCN released updates to its practice guidelines on treating triple-negative breast cancer, featuring updates on sacituzumab govitecan recommendations and more.

NCCN released updates to its...

12/15/2021

Journal of Clinical Pathways

Journal of Clinical Pathways Newsletter

Editorial Correspondence

November/December 2024

Featured Article

Feature

Column

Department

Current Issue

Special Reports

Subscribe

December 2024 Volume 10 Issue 6

Specialties

Events

Year Round Education

HMP Global Products